News & Updates

Predicting which newborn will go on to develop atopic dermatitis (AD) and how severe it will be is now feasible, according to the BABY* study.

Continuous and intermittent use of tapinarof cream 1% once daily (QD) for up to 1 year is effective in patients with mild-to-severe plaque psoriasis, without serious safety concerns, according to a study. In addition, it has shown durable efficacy and a remittive effect of at least 4 months off therapy.

The status of sentinel lymph nodes (SLN) can help predict the course of the disease in patients with clinical stage IIB/C cutaneous melanoma, suggests a study.

The risk of retinal disease seems to be greater among patients with alopecia areata (AA), according to a nationwide population-based cohort study.

Patients with generalized pustular psoriasis (GPP) suffer from a heavier burden of comorbidities than the general population and comparators with psoriasis vulgaris (PV), a new study has found.

Delays in the treatment of melanoma may worsen overall (OM) and melanoma-specific mortality (MSM), suggest the results of a recent study.